These data indicated that the associations between B01A / N02BA and ALS were not due to the primary disease CAD, and the use of HMG CoA reductase inhibitors (statins) may contribute to the LDL-C-related ALS risk. This evidence concerns the gene HMGCR and amyotrophic lateral sclerosis.